Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1PC111 vs Pitavastatin and Ezetimibe in Hypercholesterolemia
NCT04643093Phase 3Completed
- Sponsor
- Orient Pharma Co., Ltd.
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of pitavastatin, ezetimibe in hypercholesterolemia, mixed dyslipidemia, sponsored by Orient Pharma Co., Ltd.. Started Aug 2020; status: completed.
02
Drugs
pitavastatinezetimibe
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT04643093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643093.